Health

Companies engaged in biotechnology, pharmaceuticals, research services, home healthcare, hospital operations, long‑term care, and the manufacture and supply of medical equipment and supplies. The sector also includes pharmaceutical retailers and providers of health‑information services. UK‑listed companies in this sector include AstraZeneca plc, GlaxoSmithKline plc, Smith & Nephew plc, Hikma Pharmaceuticals plc, ConvaTec Group plc, Spire Healthcare plc and EMIS Group plc.

One Health Group granted planning approval for Scunthorpe surgical hub

One Health Group plc has secured planning permission for its first surgical hub in Scunthorpe, Lincolnshire, set to open in late summer 2026...

July 4, 2025

AstraZeneca’s Imfinzi approved in EU for muscle-invasive bladder cancer

AstraZeneca’s Imfinzi (durvalumab) has been approved in the EU for use alongside chemotherapy before, and as monotherapy after, bladder removal surgery in adults with resectable muscle-invasive bladder cancer...

July 4, 2025

Aptamer Group raises £2m to fund growth

Aptamer Group plc has raised £2.0 million (before expenses) via a placing of new ordinary shares at 0.3p per share, representing a 21.1% discount...

July 4, 2025

One Health Group: Record Growth and New Surgical Hub Development (LON:OHGR)

One Health Group CEO Adam Binns discusses the company’s record growth and strategic future, highlighting a 28% increase in NHS patient referrals, the successful AIM listing raising £7.8 million, and plans to open their first surgical hub by next summer..

July 2, 2025

NIOX Group a ‘Buy’ with Dependable Growth and Cashflow, Singer (LON: NIOX)

NIOX continues to capitalise on both clinical and research markets, delivering consistent growth and strengthening its cash position...

July 1, 2025

One Health reshaping surgical care across northern England

One Health Group is steadily extending NHS‑backed elective care in northern England, underpinned by a 23% revenue surge and a funded surgical hub...

July 1, 2025

Aptamer advances liver fibrosis therapy with targeted gene delivery

Aptamer Group has identified a novel target using its Optimer® platform to deliver gene therapy directly to liver scarring cells...

June 30, 2025

One Health Group Record Patient Growth and a Strategic Leap with New Surgical Hubs (Video)

One Health Group CEO Adam Binns shares how record NHS patient numbers, a successful AIM listing, and the upcoming launch of their first surgical hub are fuelling the company’s growth—and why this is just the beginning...

June 27, 2025

Healthcare real‑estate innovation

Physicians Capital, led by orthopaedic surgeon Dr Conrad Ivie, is redefining medical real estate by empowering clinician practices through tailored capital solutions...

June 26, 2025

Aptamer signs licensing deal for Optimer®-Fc diagnostic reagent

Aptamer Group has entered a funded development and licensing agreement with a global life sciences company to create an Optimer®-Fc reagent for diagnostic kits. The deal includes royalties on future sales, supporting Aptamer’s recurring revenue growth...

June 25, 2025

AstraZeneca Secures U.S. FDA Accelerated Approval for Datroway in EGFR-Mutated NSCLC

Datroway approved in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer..

June 24, 2025

One Health Group reports 23% growth and surgical hub plans

One Health Group continues to expand capacity for NHS-funded care through Patient Choice, backing waiting list reduction via surgical hubs and longer-term agreements with commissioners...

June 23, 2025

GSK Plc files to broaden Arexvy use in Japan

GSK's RSV vaccine has gained regulatory approval in Japan for adults aged 18-49 at increased risk, expanding protection against this common respiratory virus...

June 20, 2025

Where structure meets silent demand

Explore the rising importance of urology in healthcare, where effective management of the genitourinary system meets growing patient demands for quality and efficiency...

June 19, 2025

Syncona proposes investment policy change

Syncona Limited is revamping its investment strategy to enhance shareholder value amid challenging biotech market conditions. Explore their proposed policy changes and cash return options...

June 19, 2025

EDX Medical and Spire Healthcare sign MOU for diagnostic partnership

EDX Medical Group has partnered with Spire Healthcare to enhance digital diagnostics for cancer and other diseases, promising innovative patient care and improved outcomes...

June 16, 2025

Smith & Nephew appoints David King as Non-Executive Director

Smith & Nephew Plc announces the addition of David King as an independent Non-Executive Director, effective July 1, 2025, enhancing their healthcare leadership...

June 13, 2025

GSK Plc seeks EMA approval for RSV vaccine in adults 18+

GSK's RSV vaccine, Arexvy, is set for expanded use in adults 18+, following EMA's acceptance. This breakthrough addresses a critical need in respiratory health...

June 13, 2025

Empowering patient choice in healthcare

In an evolving healthcare landscape, One Health Group champions patient empowerment by offering flexible self-referral and GP referral options for tailored medical care...

June 11, 2025

AstraZeneca Plc secures EU approval for fixed-term CLL regimen

AstraZeneca's Calquence, combined with venetoclax, has received EU approval for treating untreated chronic lymphocytic leukaemia, showing promising trial results...

June 6, 2025

News and Interview Alerts

Company Presentations

Accrol Group Holdings Investor Presentation 2023

TEAM Plc’s Mark Clubb reviews 2022 and sets out the Company plans for 2023

Enteq Technologies Investor Presentation 2023

R&Q Insurance Holdings overview, investment case and progress (VIDEO)

Q&As

Atalaya Mining “superbly positioned” for rising demand and profits highlights fund manager (LON:ATYM)

13 October 2025

Record plc services becoming “much more valuable” explains upbeat DIVI fund manager (LON:REC)

13 October 2025

Victorian Plumbing Group “in stronger position with extra capacity” says fund manager (LON:VIC)

10 October 2025

CMC Markets plc software stack, scale-up potential and cash generation excites Gervais Williams (LON:CMCX)

10 October 2025

Fund manager interview on Diversified Energy – US gas, fantastic yield and growing US base (LON:DEC)

10 October 2025

Hardman & Co

NB Private Equity Partners 2025 CMD: good returns from low-risk PE model

10 December 2025

Real Estate Credit Investments (RECI): Investor Day: opportunities aplenty

2 December 2025

Volta Finance: Liquid access to outperforming private credit

6 October 2025

Real Estate Credit Investments: What RECI brings to investors

15 September 2025

Chesnara Plc: Showing good operational progress

8 September 2025

Green News

Drax expands FlexGen platform with Flexitricity acquisition

21 January 2026

View all Sustainable sectors, Plcs and news >>

Search

Latest Interviews

Ferro-Alloy Resources: Vanadium Giant Unveils Feasibility Win and Massive Phase Two Upside (Video)

Why Real Estate Credit Investments’ Resilience Could Be an Investor’s Hidden Advantage (Video)

Great Western Mining Drills Turn Early at West Huntoon as Copper Hunt Accelerates (Video)

Ampeak Energy Financial Close on AW1 Ignites £100m Battery Storage Surge (Video)

The Diverse Income Trust Gervais Williams Eyes Big Gains from Gold, Gas and Tech (Video)

BrokerTalk

Avation Clears the Runway for Growth Following Strong FY25 Results – Zeus Capital

6 October 2025

Ferro-Alloy Resources Gears Up for Growth with Promising Interim Results – Shore Capital

2 October 2025

Strix Group Innovation and Expansion Keep Momentum Alive – Equity Development

2 October 2025

Ilika Accelerates Towards EV Battery Commercialisation with Jaguar Land Rover – Baden Hill

24 September 2025

Pharos Energy Secures New Egyptian Concession, Enhancing Portfolio Value – Shore Capital

24 September 2025

Funds

CQS Natural Resources Growth & Income plc

CQS Natural Resources Growth and Income double-digit NAV and share price gains in Dec 2025

22 January 2026

RECI reports strong longer-term NAV performance to December 2025

20 January 2026

Oil’s slide creates opening as market sentiment shifts | Ruffer Investment Company

16 January 2026

How FCSS is harnessing China’s innovation – Kepler Research

15 January 2026

View all Funds, Market Insights and news >>

FTSE 100 News

UK Broker Ratings

Spire Healthcare Group PLC (SPI.L) Stock Analysis: Navigating a 48.47% Potential Upside Amid Market Challenges

22 January 2026

Dr. Martens PLC (DOCS.L) Stock Analysis: Exploring the 35% Potential Upside in a Challenging Market

22 January 2026

Syncona Limited (SYNC.L) Stock Analysis: Analyst Consensus Points to Stunning 104% Upside

22 January 2026

Senior plc (SNR.L) Stock Analysis: Navigating the Aerospace & Defense Landscape with a 2.7% Upside

22 January 2026

Softcat PLC (SCT.L) Stock Analysis: A Strong ROI with 28% Potential Upside for Tech Investors

22 January 2026

November 24, 2025

One Health Group granted planning approval for Scunthorpe surgical hub

One Health Group plc has secured planning permission for its first surgical hub in Scunthorpe, Lincolnshire, set to open in late summer 2026...

July 4, 2025

AstraZeneca’s Imfinzi approved in EU for muscle-invasive bladder cancer

July 4, 2025

Aptamer Group raises £2m to fund growth

Aptamer Group plc has raised £2.0 million (before expenses) via a placing of new ordinary shares at 0.3p per share, representing a 21.1% discount...

July 4, 2025

One Health Group: Record Growth and New Surgical Hub Development (LON:OHGR)

July 2, 2025

NIOX Group a ‘Buy’ with Dependable Growth and Cashflow, Singer (LON: NIOX)

NIOX continues to capitalise on both clinical and research markets, delivering consistent growth and strengthening its cash position...

July 1, 2025

One Health reshaping surgical care across northern England

One Health Group is steadily extending NHS‑backed elective care in northern England, underpinned by a 23% revenue surge and a funded surgical hub...

July 1, 2025

Aptamer advances liver fibrosis therapy with targeted gene delivery

Aptamer Group has identified a novel target using its Optimer® platform to deliver gene therapy directly to liver scarring cells...

June 30, 2025

One Health Group Record Patient Growth and a Strategic Leap with New Surgical Hubs (Video)

June 27, 2025

Healthcare real‑estate innovation

Physicians Capital, led by orthopaedic surgeon Dr Conrad Ivie, is redefining medical real estate by empowering clinician practices through tailored capital solutions...

June 26, 2025

Aptamer signs licensing deal for Optimer®-Fc diagnostic reagent

June 25, 2025

AstraZeneca Secures U.S. FDA Accelerated Approval for Datroway in EGFR-Mutated NSCLC

Datroway approved in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer..

June 24, 2025

One Health Group reports 23% growth and surgical hub plans

One Health Group continues to expand capacity for NHS-funded care through Patient Choice, backing waiting list reduction via surgical hubs and longer-term agreements with commissioners...

June 23, 2025

GSK Plc files to broaden Arexvy use in Japan

GSK's RSV vaccine has gained regulatory approval in Japan for adults aged 18-49 at increased risk, expanding protection against this common respiratory virus...

June 20, 2025

Where structure meets silent demand

Explore the rising importance of urology in healthcare, where effective management of the genitourinary system meets growing patient demands for quality and efficiency...

June 19, 2025

Syncona proposes investment policy change

Syncona Limited is revamping its investment strategy to enhance shareholder value amid challenging biotech market conditions. Explore their proposed policy changes and cash return options...

June 19, 2025

EDX Medical and Spire Healthcare sign MOU for diagnostic partnership

EDX Medical Group has partnered with Spire Healthcare to enhance digital diagnostics for cancer and other diseases, promising innovative patient care and improved outcomes...

June 16, 2025

Smith & Nephew appoints David King as Non-Executive Director

Smith & Nephew Plc announces the addition of David King as an independent Non-Executive Director, effective July 1, 2025, enhancing their healthcare leadership...

June 13, 2025

GSK Plc seeks EMA approval for RSV vaccine in adults 18+

GSK's RSV vaccine, Arexvy, is set for expanded use in adults 18+, following EMA's acceptance. This breakthrough addresses a critical need in respiratory health...

June 13, 2025

Empowering patient choice in healthcare

In an evolving healthcare landscape, One Health Group champions patient empowerment by offering flexible self-referral and GP referral options for tailored medical care...

June 11, 2025

AstraZeneca Plc secures EU approval for fixed-term CLL regimen

AstraZeneca's Calquence, combined with venetoclax, has received EU approval for treating untreated chronic lymphocytic leukaemia, showing promising trial results...

June 6, 2025